In the single-arm FULCRUM-VT trial, 59% of patients remained free of recurrent VT at 6 months, with less amiodarone use.

Data from three RCTs show a level of ≥ 175 nmol/L, not ≥ 125 nmol/L, is an independent predictor of death and stroke.

Disease pattern is a strong modifier of how much PCI will reduce angina and may explain prior negative trials in this space.

COMPASS presents a “scalable framework” for other centers that want to improve AF care, but additional efforts are needed.

There are both clinical and economic implications, as payers have been discouraging ablation in this population, one expert ...

A data-driven, collaborative program failed to lead to noticeable gains in the trial, but a researcher says the search isn’t ...

The SENIOR-RITA data suggest medical therapy is a better option for older, severely frail NSTEMI patients, says Vinay ...

The study questions whether it may be best to wait to implant a support device until arriving at a level 1 shock center.

Preliminary 3-Year SIRONA Data Presented at CX-2026 Demonstrate Durable Freedom from Reintervention with MagicTouch PTA in ...

People with mildly reduced ejection fraction, a distinct group with unique needs, account for nearly one-quarter of HF cases.

The data show a correlation between wound healing and better participation in social activities, better sleeping habits, and ...

Early right-heart stabilization seems to be translating to better QoL and faster return of function, says Robert Lookstein.